Indeed, expression of β8 integrin by cells that rely on TGF-β for their immunosuppressive effects, such as tumor cells [134] or Treg cells [135], controls some TGF-β-associated events, and blockade of this integrin results in antitumor activity in several preclinical murine models. This evidence concerns the gene TGFB1 and neoplasm.